Global Senolytic Drug Market Research Report 2024

Report ID: 1919365 | Published Date: Jan 2025 | No. of Page: 84 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Senolytic Drug Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 FOXO4-related Peptides
        1.2.3 Bcl-2 Family Inhibitors
        1.2.4 Navitoclax
        1.2.5 Dasatinib and Quercetin
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Senolytic Drug Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Retail Pharmacies
        1.3.3 Hospital Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Senolytic Drug Market Perspective (2017-2028)
    2.2 Senolytic Drug Growth Trends by Region
        2.2.1 Senolytic Drug Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Senolytic Drug Historic Market Size by Region (2017-2022)
        2.2.3 Senolytic Drug Forecasted Market Size by Region (2023-2028)
    2.3 Senolytic Drug Market Dynamics
        2.3.1 Senolytic Drug Industry Trends
        2.3.2 Senolytic Drug Market Drivers
        2.3.3 Senolytic Drug Market Challenges
        2.3.4 Senolytic Drug Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Senolytic Drug Players by Revenue
        3.1.1 Global Top Senolytic Drug Players by Revenue (2017-2022)
        3.1.2 Global Senolytic Drug Revenue Market Share by Players (2017-2022)
    3.2 Global Senolytic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Senolytic Drug Revenue
    3.4 Global Senolytic Drug Market Concentration Ratio
        3.4.1 Global Senolytic Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Senolytic Drug Revenue in 2021
    3.5 Senolytic Drug Key Players Head office and Area Served
    3.6 Key Players Senolytic Drug Product Solution and Service
    3.7 Date of Enter into Senolytic Drug Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Senolytic Drug Breakdown Data by Type
    4.1 Global Senolytic Drug Historic Market Size by Type (2017-2022)
    4.2 Global Senolytic Drug Forecasted Market Size by Type (2023-2028)
5 Senolytic Drug Breakdown Data by Application
    5.1 Global Senolytic Drug Historic Market Size by Application (2017-2022)
    5.2 Global Senolytic Drug Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Senolytic Drug Market Size (2017-2028)
    6.2 North America Senolytic Drug Market Size by Country (2017-2022)
    6.3 North America Senolytic Drug Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Senolytic Drug Market Size (2017-2028)
    7.2 Europe Senolytic Drug Market Size by Country (2017-2022)
    7.3 Europe Senolytic Drug Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Senolytic Drug Market Size (2017-2028)
    8.2 Asia-Pacific Senolytic Drug Market Size by Country (2017-2022)
    8.3 Asia-Pacific Senolytic Drug Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Senolytic Drug Market Size (2017-2028)
    9.2 Latin America Senolytic Drug Market Size by Country (2017-2022)
    9.3 Latin America Senolytic Drug Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Senolytic Drug Market Size (2017-2028)
    10.2 Middle East & Africa Senolytic Drug Market Size by Country (2017-2022)
    10.3 Middle East & Africa Senolytic Drug Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 AgeX Therapeutics, Inc.
        11.1.1 AgeX Therapeutics, Inc. Company Detail
        11.1.2 AgeX Therapeutics, Inc. Business Overview
        11.1.3 AgeX Therapeutics, Inc. Senolytic Drug Introduction
        11.1.4 AgeX Therapeutics, Inc. Revenue in Senolytic Drug Business (2017-2022)
        11.1.5 AgeX Therapeutics, Inc. Recent Development
    11.2 Cleara Biotech
        11.2.1 Cleara Biotech Company Detail
        11.2.2 Cleara Biotech Business Overview
        11.2.3 Cleara Biotech Senolytic Drug Introduction
        11.2.4 Cleara Biotech Revenue in Senolytic Drug Business (2017-2022)
        11.2.5 Cleara Biotech Recent Development
    11.3 Eternans Ltd.
        11.3.1 Eternans Ltd. Company Detail
        11.3.2 Eternans Ltd. Business Overview
        11.3.3 Eternans Ltd. Senolytic Drug Introduction
        11.3.4 Eternans Ltd. Revenue in Senolytic Drug Business (2017-2022)
        11.3.5 Eternans Ltd. Recent Development
    11.4 FoxBio Inc
        11.4.1 FoxBio Inc Company Detail
        11.4.2 FoxBio Inc Business Overview
        11.4.3 FoxBio Inc Senolytic Drug Introduction
        11.4.4 FoxBio Inc Revenue in Senolytic Drug Business (2017-2022)
        11.4.5 FoxBio Inc Recent Development
    11.5 Numeric Biotech
        11.5.1 Numeric Biotech Company Detail
        11.5.2 Numeric Biotech Business Overview
        11.5.3 Numeric Biotech Senolytic Drug Introduction
        11.5.4 Numeric Biotech Revenue in Senolytic Drug Business (2017-2022)
        11.5.5 Numeric Biotech Recent Development
    11.6 T.A. Sciences, Inc.
        11.6.1 T.A. Sciences, Inc. Company Detail
        11.6.2 T.A. Sciences, Inc. Business Overview
        11.6.3 T.A. Sciences, Inc. Senolytic Drug Introduction
        11.6.4 T.A. Sciences, Inc. Revenue in Senolytic Drug Business (2017-2022)
        11.6.5 T.A. Sciences, Inc. Recent Development
    11.7 Recursion Pharmaceuticals, Inc.
        11.7.1 Recursion Pharmaceuticals, Inc. Company Detail
        11.7.2 Recursion Pharmaceuticals, Inc. Business Overview
        11.7.3 Recursion Pharmaceuticals, Inc. Senolytic Drug Introduction
        11.7.4 Recursion Pharmaceuticals, Inc. Revenue in Senolytic Drug Business (2017-2022)
        11.7.5 Recursion Pharmaceuticals, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Senolytic Drug Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of FOXO4-related Peptides
    Table 3. Key Players of Bcl-2 Family Inhibitors
    Table 4. Key Players of Navitoclax
    Table 5. Key Players of Dasatinib and Quercetin
    Table 6. Key Players of Others
    Table 7. Global Senolytic Drug Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Senolytic Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Senolytic Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Senolytic Drug Market Share by Region (2017-2022)
    Table 11. Global Senolytic Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Senolytic Drug Market Share by Region (2023-2028)
    Table 13. Senolytic Drug Market Trends
    Table 14. Senolytic Drug Market Drivers
    Table 15. Senolytic Drug Market Challenges
    Table 16. Senolytic Drug Market Restraints
    Table 17. Global Senolytic Drug Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Senolytic Drug Market Share by Players (2017-2022)
    Table 19. Global Top Senolytic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Senolytic Drug as of 2021)
    Table 20. Ranking of Global Top Senolytic Drug Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Senolytic Drug Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Senolytic Drug Product Solution and Service
    Table 24. Date of Enter into Senolytic Drug Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Senolytic Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Senolytic Drug Revenue Market Share by Type (2017-2022)
    Table 28. Global Senolytic Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Senolytic Drug Revenue Market Share by Type (2023-2028)
    Table 30. Global Senolytic Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Senolytic Drug Revenue Market Share by Application (2017-2022)
    Table 32. Global Senolytic Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Senolytic Drug Revenue Market Share by Application (2023-2028)
    Table 34. North America Senolytic Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Senolytic Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Senolytic Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Senolytic Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Senolytic Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Senolytic Drug Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Senolytic Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Senolytic Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Senolytic Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Senolytic Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 44. AgeX Therapeutics, Inc. Company Detail
    Table 45. AgeX Therapeutics, Inc. Business Overview
    Table 46. AgeX Therapeutics, Inc. Senolytic Drug Product
    Table 47. AgeX Therapeutics, Inc. Revenue in Senolytic Drug Business (2017-2022) & (US$ Million)
    Table 48. AgeX Therapeutics, Inc. Recent Development
    Table 49. Cleara Biotech Company Detail
    Table 50. Cleara Biotech Business Overview
    Table 51. Cleara Biotech Senolytic Drug Product
    Table 52. Cleara Biotech Revenue in Senolytic Drug Business (2017-2022) & (US$ Million)
    Table 53. Cleara Biotech Recent Development
    Table 54. Eternans Ltd. Company Detail
    Table 55. Eternans Ltd. Business Overview
    Table 56. Eternans Ltd. Senolytic Drug Product
    Table 57. Eternans Ltd. Revenue in Senolytic Drug Business (2017-2022) & (US$ Million)
    Table 58. Eternans Ltd. Recent Development
    Table 59. FoxBio Inc Company Detail
    Table 60. FoxBio Inc Business Overview
    Table 61. FoxBio Inc Senolytic Drug Product
    Table 62. FoxBio Inc Revenue in Senolytic Drug Business (2017-2022) & (US$ Million)
    Table 63. FoxBio Inc Recent Development
    Table 64. Numeric Biotech Company Detail
    Table 65. Numeric Biotech Business Overview
    Table 66. Numeric Biotech Senolytic Drug Product
    Table 67. Numeric Biotech Revenue in Senolytic Drug Business (2017-2022) & (US$ Million)
    Table 68. Numeric Biotech Recent Development
    Table 69. T.A. Sciences, Inc. Company Detail
    Table 70. T.A. Sciences, Inc. Business Overview
    Table 71. T.A. Sciences, Inc. Senolytic Drug Product
    Table 72. T.A. Sciences, Inc. Revenue in Senolytic Drug Business (2017-2022) & (US$ Million)
    Table 73. T.A. Sciences, Inc. Recent Development
    Table 74. Recursion Pharmaceuticals, Inc. Company Detail
    Table 75. Recursion Pharmaceuticals, Inc. Business Overview
    Table 76. Recursion Pharmaceuticals, Inc. Senolytic Drug Product
    Table 77. Recursion Pharmaceuticals, Inc. Revenue in Senolytic Drug Business (2017-2022) & (US$ Million)
    Table 78. Recursion Pharmaceuticals, Inc. Recent Development
    Table 79. Research Programs/Design for This Report
    Table 80. Key Data Information from Secondary Sources
    Table 81. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Senolytic Drug Market Share by Type: 2021 VS 2028
    Figure 2. FOXO4-related Peptides Features
    Figure 3. Bcl-2 Family Inhibitors Features
    Figure 4. Navitoclax Features
    Figure 5. Dasatinib and Quercetin Features
    Figure 6. Others Features
    Figure 7. Global Senolytic Drug Market Share by Application in 2021 & 2028
    Figure 8. Retail Pharmacies Case Studies
    Figure 9. Hospital Pharmacies Case Studies
    Figure 10. Online Pharmacies Case Studies
    Figure 11. Senolytic Drug Report Years Considered
    Figure 12. Global Senolytic Drug Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Senolytic Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Senolytic Drug Market Share by Region: 2021 VS 2028
    Figure 15. Global Senolytic Drug Market Share by Players in 2021
    Figure 16. Global Top Senolytic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Senolytic Drug as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Senolytic Drug Revenue in 2021
    Figure 18. North America Senolytic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Senolytic Drug Market Share by Country (2017-2028)
    Figure 20. United States Senolytic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Senolytic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Senolytic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Senolytic Drug Market Share by Country (2017-2028)
    Figure 24. Germany Senolytic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Senolytic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Senolytic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Senolytic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Senolytic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Senolytic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Senolytic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Senolytic Drug Market Share by Region (2017-2028)
    Figure 32. China Senolytic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Senolytic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Senolytic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Senolytic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Senolytic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Senolytic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Senolytic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Senolytic Drug Market Share by Country (2017-2028)
    Figure 40. Mexico Senolytic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Senolytic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Senolytic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Senolytic Drug Market Share by Country (2017-2028)
    Figure 44. Turkey Senolytic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Senolytic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. AgeX Therapeutics, Inc. Revenue Growth Rate in Senolytic Drug Business (2017-2022)
    Figure 47. Cleara Biotech Revenue Growth Rate in Senolytic Drug Business (2017-2022)
    Figure 48. Eternans Ltd. Revenue Growth Rate in Senolytic Drug Business (2017-2022)
    Figure 49. FoxBio Inc Revenue Growth Rate in Senolytic Drug Business (2017-2022)
    Figure 50. Numeric Biotech Revenue Growth Rate in Senolytic Drug Business (2017-2022)
    Figure 51. T.A. Sciences, Inc. Revenue Growth Rate in Senolytic Drug Business (2017-2022)
    Figure 52. Recursion Pharmaceuticals, Inc. Revenue Growth Rate in Senolytic Drug Business (2017-2022)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AgeX Therapeutics, Inc.
Cleara Biotech
Eternans Ltd.
FoxBio Inc
Numeric Biotech
T.A. Sciences, Inc.
Recursion Pharmaceuticals, Inc.
Frequently Asked Questions
Senolytic Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Senolytic Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Senolytic Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Negatoscope

Due to the COVID-19 pandemic, the global Negatoscope market size is estimated to be worth US$ mi ... Read More

LKS Treatment

Market Analysis and Insights: Global LKS Treatment Market
The global LKS Treatment  ... Read More